| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |